With D`Oxyva, 'The proof is in the pudding,’ and when customers see the results they obtain, they will quickly spread the word to friends and family.
Pasadena, CA (PRWEB) October 12, 2011
InvisiDerm Healthcare (“InvisiDerm” or “the Company”), an emerging developer and manufacturer of novel transdermal drug delivery methods, announces that it is launching its online store to coincide with special promotional pricing for its flagship regenerative skin therapy product D`Oxyva™.
The savings on D`Oxyva™ are being offered through November 15th and are available exclusively through the new D`Oxyva™ online store http://www.doxyva.com. The D`Oxyva™ transdermal delivery device, normally priced at $299, is being reduced to just $99 during this special promotional period. Similarly, a 24 pack of carbon dioxide cartridges used to administer D`Oxyva™ treatments is also being offered for just $99, more than half off its regular price.
D`Oxyva™ is a powerful, all natural skin treatment that works locally on specific skin problems such as wrinkles, scars, and discoloration. The therapy is designed to help skin look younger and become healthier while enhancing the effectiveness of other skin-health and cosmetic products by activating natural regenerative processes within the body's micro-circulatory system.
Unlike so many other skin treatments, the powerful D`Oxyva™ therapy is completely noninvasive and easy to administer, delivering its benefits transdermally (to the skin), without needles or discomfort, in just 5 minutes per treatment.
Once applied to a region of healthy skin near the desired area of treatment, D`Oxyva™ begins working immediately to improve skin health and beauty, and reduce the appearance of fat, cellulite, wrinkles and scars by instantly amplifying the skin's own natural detoxification and nutrient delivery mechanisms. It is believed that these mechanisms are enhanced as a result of improved oxygen-rich capillary blood flow in the skin tissue.
InvisiDerm is offering the temporarily discounted pricing in order to introduce the novel D`Oxyva™ therapy to a broader number of users as it continues with the full-scale rollout of D`Oxyva™ to the skin care market.
Discussing the promotional pricing, InvisiDerm CEO Norbert Kiss commented, “We recognize that our therapy is new to many customers, and we want to make it easily accessible for them to purchase and try it out for themselves. We strongly believe that ‘the proof is in the pudding,’ and when customers see the results they obtain, they will quickly spread the word to friends and family.”
D`Oxyva™ has already begun creating a substantial buzz amongst early-adopting professional users who have tried the therapy on their clients – and on themselves. According to Nina Curtis, owner of the Nile Institute, a holistic skin care and wellness center in West Hollywood, CA,
“It all makes sense! D`Oxyva™, by InvisiDerm™ Healthcare, is a truly noninvasive and all natural transdermal oxygen therapy that is delivered safely via the skin. As a professional holistic skin care specialist and wellness coach, I am very excited about this technology and what it means not only to my business, but to the health of my clients' skin and their overall well-being. The benefits that caught my attention most were D`Oxyva™’s ability to assist in detoxifying the body, combat stress, eliminate the appearance of fat and cellulite, and reduce the appearance of fine lines and wrinkles. I love the results that I am experiencing personally, such as increased energy, skin vibrancy, and clarity of mind.”
The special pricing is available through November 15th, and it is available only at http://www.doxyva.com.
About InvisiDerm Healthcare (http://www.MyInvisiDerm.info)
InvisiDerm, LLC, d/b/a/ InvisiDerm Healthcare, is an early stage medical device company in the United States that designs, develops, manufactures and markets groundbreaking, proprietary, truly noninvasive, and highly portable medical gas-powered transdermal delivery devices and accessories made in the USA. The Company has started manufacturing its initial product line in 2011, using its D’Oxyva™ oxygen therapy platform with the intention of targeting the spa, health-and–beauty, and anti-aging markets in the future. More broadly, InvisiDerm is aiming to make hypodermic needle drug delivery obsolete and rapidly revolutionize the double-digit growth, multi-billion dollar transdermal drug delivery (TDD) industry with its next-generation products. The Company is headquartered in Pasadena, California.
This press release may contain “forward-looking information”. This forward-looking information includes, or may be based upon, estimates, forecasts, and statements as to management’s expectations with respect to, among other things, the quality of the products of InvisiDerm Healthcare, its resources, progress in development, and demand and market outlook for noninvasive transdermal delivery medical devices in general. Forward-looking information is based on the opinions and estimates of management at the date the information is given, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. These factors include the inherent risks involved in the launch of a new medical device, the uncertainties involved in innovation and market acceptance, fluctuating component and other raw and advanced material prices, new federal or state governmental regulations, the possibility of project cost overruns or unanticipated costs and expenses, uncertainties relating to the availability and costs of financing needed in the future and other factors. The forward-looking information contained herein is given as of the date hereof and InvisiDerm Healthcare assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law. InvisiDerm Healthcare makes no representations or warranties as to the accuracy or completeness of this press release and shall have no liability for any representations (expressed or implied) for any statement made herein, or for any omission from this press release.
For More Information
Please visit http://www.MyInvisiDerm.info and send your general inquiries via the Contact Us page, or for specific inquiries contact InvisiDerm Public Relations at pr(at)myinvisiderm(dot)info or by phone at +1 (626) 817-6685.
Copyright © 2011 InvisiDerm Healthcare. All rights reserved. The InvisiDerm star logo, InvisiDerm, and D’Oxyva are either registered trademarks or trademarks of InvisiDerm Healthcare in the United States and other countries.